Sales results for the 4th quarter and 2015

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sales results for the 4th quarter and 2015
Segments (EURm) Q4/15 Q4/14 yoy 12m/15 12m/14 yoy
Supermarkets 104.2 99.2 5.0% 383.5 368.2 4.2%
Department stores 29.1 28.4 2.4% 95.6 92.5 3.3%
Cars 15.2 13.9 9.0% 60.8 57.7 5.3%
Footwear 3.4 3.2 7.7% 11.9 13.4 -10.7%
Real Estate 1.2 0.8 38.5% 3.7 3.3 12.6%
Total sales 153.0 145.5 5.1% 555.5 535.0 3.8%

The consolidated unaudited sales revenue of the Tallinna Kaubamaja Group in 2015 was 555.5 million euros, having grown by 3.8% compared to the result of 2014, when the sales revenue was 535.0 million euros. In the 4th quarter, the group’s sales revenue was 153.0 million euros, which is 5.1% more than the sales revenue earned the year before. Revenue growth was in line with the Group's expectations.

The consolidated sales revenue of the supermarket segment in the 2015 was 383.5 million euros, a year-on-year growth of 4.2%. The consolidated sales revenue of the 4th quarter was 104.2 million euros, having grown by 5.0% compared to the same period in the previous year. The sales revenue of goods in comparable stores for the 4th quarter of 2015 was indicating an increase of 2.2%, in summary comparable net sales of 2015 increased for 1.5%.

The sales revenue of the department store business segment for the 2015 was 95.6 million euros, having grown by 3.3% compared to the previous year. Of that, the sales revenue of the 4th quarter was 29.1 million euros, 2.4% more than the revenue of the 4th quarter 2014. The sales revenue of OÜ TKM Beauty Eesti, which operates the I.L.U. beauty stores, was 5.1 million euros in the 2015, 9.0% higher than in the previous year. Of that, the sales revenue of the 4th quarter was 1.7 million euros, 6.4% more compared to the comparable period of 2014.

The sales revenue of the vehicle trade segment for the 2015 was 60.8 million euros. The sales revenue exceeded the revenue of the last year by 5.3%; the sales revenue of KIAs increased by 7.1%. The sales revenue of 15.2 million euros generated in the 4th quarter was higher than the sales revenue of the year before by 9.0%; the sales revenue of KIAs increased by 3.4%.

The sales revenue of the footwear segment in the 2015 was 11.9 million euros, having decreased by 10.7% in a year. In the 4th quarter, the turnover was 3.4 million euros, showing an increase of 7.7% compared to the same period of 2014.

The sales revenue of the business segment of real estate outside the Group totalled to 3.7 million euros in 2015. Sales revenue increased 12.6% compared to the previous year. The extra-Group sales revenue of the 4th quarter was 1.2 million euros, having increased by 38.5% compared to the same period of the previous year. The sales revenue of the 4th quarter was supported by the successful opening of the Viimsi centre in August 2015, also the Rezekne building in Latvia was rented out to the external party.

         Raul Puusepp          Chairman of the Board          Phone +372 731 5000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 39

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 46

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 48

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 44

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 50

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 61

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 58

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Cemtrex's Stock Surge Sparks Interest in Leading Movers

Updated Category News Views 117

Cemtrex Experiences Notable Share Surge Shares of Cemtrex, Inc. CETX have seen a significant uptick amid pre-market trading. This boost comes on the heels of better-than-expected sales in the latest quarter, reporting an impressive $18.10 million in sales, surpassing the general analyst expectation of $16.39 million. This remarkable performance in sales has sparked...

Continue Reading
Exciting New PharmD-MBA Pathway Combines Pharmacy and Business

Updated Category News Views 193

Collaboration between Cal Poly Pomona and Western University In an exciting move, Cal Poly Pomona's Singelyn Graduate School of Business and Western University of Health Sciences have teamed up to create a groundbreaking pathway for aspiring healthcare professionals. This innovative PharmD-MBA program combines the fields of pharmacy and business, providing a unique...

Continue Reading
Kaskela Law Investigates Stock Misconduct in Stanley Black & Decker

Updated Category News Views 155

Overview of the Investigation by Kaskela Law LLC Kaskela Law LLC has announced an important investigation focused on Stanley Black & Decker, Inc. (NYSE: SWK) concerning allegations of potential securities fraud. This inquiry is primarily aimed at safeguarding the interests of long-term investors who hold shares in this well-known manufacturing company. Details Surrounding...

Continue Reading
Legend Biotech's Carvykti: A Leading Force in Cancer Treatment

Updated Category News Views 90

Redburn's Positive Outlook for Legend Biotech Recently, Redburn-Atlantic began covering Legend Biotech Corp. (NASDAQ: LEGN) with a favorable Buy rating and set a price target of $86.00 for the stock. This biotechnology company has made significant strides, particularly with the recent approval of its innovative product, Carvykti, designed for the treatment of multiple...

Continue Reading
Transforming the Anti-Obesity Drug Market for Future Success

Updated Category News Views 132

Global Anti-Obesity Drug Market Overview As global health concerns rise, the demand for anti-obesity drugs is surging. Recent reports estimate that the anti-obesity drug market will soar to USD 82.55 billion in the coming years. This impressive growth, fueled by an anticipated compound annual growth rate (CAGR) of 18.01%, signals a crucial moment for pharmaceutical...

Continue Reading